Korean J Intern Med.
2023 Jul;38(4):578-578. 10.3904/kjim.2022.183e.
Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma
- Cho HJ1
- Jo JC2
- Lee YJ2
- Lee MW3
- Kim DY4
- Shin HJ4
- Im SN5
- Lee JH6
- Bae SH7
- Do YR8
- Lee WS9
- Kim MK10
- Jung J1
- Lee JM1
- Kim JH1
- Baek DW1
- Sohn SK1
- Moon JH
1
- Affiliations
-
- 1Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea
- 2Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
- 3Department of Hematology-Oncology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea
- 4Department of Hematology-Oncology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea
- 5Department of Hematology- Oncology, Inje University Haeundae Paik Hospital, Busan, Korea
- 6Department of Hematology-Oncology, Dong-A University Hospital, Busan, Korea
- 7Department of Hematology-Oncology, Daegu Catholic University Hospital, Daegu Catholic University School of Medicine, Daegu, Korea
- 8Department of Hematology-Oncology, Keimyung University School of Medicine, Daegu, Korea
- 9Department of Hematology-Oncology, Inje University Busan Paik Hospital, Busan, Korea
- 10Department of Hematology-Oncology, Yeungnam University Hospital, Daegu, Korea
- KMID: 2544206
- DOI: http://doi.org/10.3904/kjim.2022.183e
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma
- Treatment of relapsed and refractory multiple myeloma
- A Case of Panagglutination on Antibody Identification in a Multiple Myeloma Patient Receiving Daratumumab
- Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second
- Prognostic Significance of Absolute Lymphocyte Count/Absolute Monocyte Count Ratio at Diagnosis in Patients with Multiple Myeloma
